L. Green

发表

mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors

B. Aronow, N. Mackman, H. Versteeg, 2018, Journal of thrombosis and haemostasis : JTH.

Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels

Sheryl E. Koch, Nathan Robbins, Jack Rubinstein, 2018, Journal of cardiovascular pharmacology.

Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.

C. Mantzoros, D. Sanoudou, F. Stillitano, 2022, Metabolism: clinical and experimental.

Adipocyte deletion of the RNA binding protein HuR induces cardiac hypertrophy and fibrosis

J. Benoit, P. Alam, M. Nieman, 2021, bioRxiv.

l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo

Melanie C. McKell, K. Setchell, L. Schlesinger, 2019, The Journal of Immunology.

Adipocyte deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis.

J. Benoit, A. P. Owens, P. Alam, 2021, American journal of physiology. Heart and circulatory physiology.

HuR inhibition reduces post-ischemic cardiac remodeling by dampening acute inflammatory gene expression and the innate immune response

J. Aubé, A. P. Owens, P. Alam, 2023, bioRxiv.

Human antigen R as a therapeutic target in pathological cardiac hypertrophy.

Nathan Robbins, Jack Rubinstein, J. Lorenz, 2019, JCI insight.

HuR-dependent expression of Wisp1 is necessary for TGFβ-induced cardiac myofibroblast activity

J. Aubé, Liang Xu, Xiaoqing Wu, 2022, bioRxiv.

Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias

Sheryl E. Koch, D. Sanoudou, F. Stillitano, 2021, Journal of personalized medicine.

HuR expression in adipose tissue mediates energy expenditure and acute thermogenesis independent of UCP1 expression

M. Tranter, Sarah R. Anthony, Adrienne R. Guarnieri, 2020, Adipocyte.

Human antigen R as a therapeutic target in pathological cardiac hypertrophy.

Nathan Robbins, Jack Rubinstein, Liang Xu, 2019, JCI insight.